期刊文献+

2-(α-羟烷基)-苯并咪唑衍生物的合成 被引量:2

Synthesis of 2-(α-Hydroxyalkyl)-benzimidazole Derivatives
在线阅读 下载PDF
导出
摘要 经还原、缩合两步反应以4-甲基-2-硝基苯胺为初始原料,在50 ℃条件下与Raney Ni(活性Ni)反应得到咖啡色粉末状对甲基邻苯二胺固体.然后将对甲基邻苯二胺在回流状态下与乙醇酸反应得到墨绿色溶液,经处理后得到的灰白色固体脱色并且干燥后得到白色粉末状的 6-甲基-2-(α-羟烷基)-1H-苯并咪唑.以及对甲基邻苯二胺在回流状态下与柠檬酸反应得到草绿色黏稠液体,经处理后得到的绿色泥状固体重结晶后得到黄色粉末状的1, 2, 3-三(5-甲基-1H-苯并咪唑-2-)-2-丙醇等4种2-(α-羟烷基)-苯并咪唑衍生物.其中有三种为新化合物.所有化合物均经熔点、IR、1HNMR或13CNMR结构确认. Brown powdery p-methyl-phenylenediamine solid was prepared from 4-methyl-2-nitroaniline and Raney Ni at 50°C via the reduction and condensation two-step reactions.Then,p-methylphenylene diamine reacted with glycolic acid under reflux to obtain a dark green solution,and 6-methyl-2-(α-hydroxyalkyl)-1H-benzimidazole white powder was obtained via the decolorization and drying.And p-methylphenylenediamine reacted with the citric acid under reflux to obtain a grassy green viscous liquid,and four kinds of 2-(α-hydroxyalkyl)-benzidine derivatives,for example 1,2,3-tris(5-methyl-1H-benzimidazole-2-)-2-propanol,were obtained via the recrystallization.The other three derivatives were new compounds.All compounds were confirmed by melting point,1HNMR or 13CNMR.
作者 李晨阳 马圆 吴文瀚 倪洁 陈定奔 LI Chen-yang;MA Yuan;WU Wen-han;NI Jie;CHEN Ding-ben(College of Pharmaceutical and Chemical Engineering,Taizhou University,Zhejiang Taizhou 318000,China)
出处 《当代化工》 CAS 2019年第10期2313-2316,共4页 Contemporary Chemical Industry
基金 浙江省自然科学基金资助项目(Y18B020005)
关键词 4-甲基-2-硝基苯胺2-(α-羟烷基)-苯并咪唑衍生物 合成 结构表征 4-methyl-2-nitroaniline-2-(α-hydroxyalkyl)-benzimidazole derivatives Synthesis Structure characte rization
作者简介 李晨阳(1997-),男,安徽亳州人,研究方向:有机合成,E-mail:ahbz.987683893@qq.com;通讯作者:陈定奔,E-mail:cdb23@163.com。
  • 相关文献

参考文献10

二级参考文献88

  • 1于萍,周柏青,朱志平.EC932型铜管酸洗缓蚀剂的性能[J].材料保护,1995,28(10):6-8. 被引量:7
  • 2毛煜,佘佳红,袁伯俊.苯并咪唑类质子泵抑制剂的药理和临床研究进展[J].中国新药杂志,2006,15(1):17-21. 被引量:28
  • 3袁勇,周成合,刘嫱,宋春泽.新型合成抗菌药物研究新进展[J].中国新药杂志,2007,16(5):343-350. 被引量:19
  • 4吴俊,米佳丽,周成合.组胺H_3受体配体研究进展[J].中国药学杂志,2007,42(6):404-409. 被引量:15
  • 5任天辉 薛群基 等.-[J].机械科学与技术,1993,:171-173.
  • 6WATANABE M, KAZUTA Y, HAYASHI H, et al. Stereochemical diversity-oriented conformational restriction strategy: Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyelopropane structure [ ] ]. J Med Chem, 2006,49(18) :5587 - 5596.
  • 7VENABLE JD, CAI H, CHAI W, et al. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: Potent human histamine H4 antagonists[ J]. J Med Chem, 2005,48(26):8289 -8298.
  • 8BORZA I, BOZO E, BARTA-SZALAI G, et al. Selective NR1/ 2B N-Methyl-d-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides[ J ] . J Med Chem , 2007,50(5) :901 -914.
  • 9GARCIA CV, NUDELMAN NS, STEPPE M, et al. Structural elucidation of rabeprazole sodium photodegradation products[ J ]. J Pharm Biomed Anal, 2008,46 ( 1 ) :88 - 93.
  • 10BALI A, BANSALM, SUGUMARAN M, et al. Design, synthesis and evaluation of novelly substituted benzimidazole compounds as angiotensin Ⅱ receptor antagonists [ J ]. Bioorg Med Chem Lett, 2005,15 ( 17 ) :3962 - 3965.

共引文献217

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部